Why the study?
Does protamine sulfate reduce left ventricular function in patients undergoing heart surgery requiring cardiopulmonary bypass?
Does protamine sulfate reduce left ventricular function in patients undergoing heart surgery requiring cardiopulmonary bypass?
Protamine administration after cardiopulmonary bypass may exert a negative inotropic effect in patients with pre-existing impaired left ventricular function.
Answers are grounded in this paper and cite their sources.
May support caution with protamine in patients with EF <50%; leaves open causality and generalizability.
The effect of protamine sulfate on left ventricular function was evaluated in 23 patients undergoing heart surgery requiring cardiopulmonary bypass (CPB). Ventricular function was assessed by measuring cardiac index with a thermodilution pulmonary artery catheter and fractional shortening with transesophageal echocardiography (TEE). After CPB, a heparin-neutralizing dose of protamine was infused continuously for 5 min. Hemodynamic variables were obtained and fractional shortening was measured before protamine administration (time 0), during protamine infusion (2.5 and 5 min), and after the infusion (10 and 15 min after the start of protamine). Patients with a preoperative ejection fraction > or = 50% had no statistically significant changes in either cardiac index or fractional shortening with protamine administration, when compared to time 0. However, patients with a preoperative ejection fraction < 50% had a significant decrease in fractional shortening which occurred during and immediately after protamine administration when compared to time 0 (P < 0.01), with no associated change in hemodynamics. Our results suggest that protamine may have a negative inotropic effect that is apparent in patients with impaired ventricular function.
No takes yet. Share an insight, caveat, or question.
Re et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: